Smead Value Investor holds a quantitatively derived Neutral Morningstar Medalist Rating. The rating suggests the model does not express a clear expectation of outperformance or underperformance relative to peers over a full market cycle.
Smead Value Fund Investor Class SMVLX
- NAV / 1-Day Return 98.39 / −0.21 %
- Total Assets 4.1B
-
Adj. Expense Ratio
1.230%
- Expense Ratio 1.170%
- Distribution Fee Level High
- Share Class Type No Load
- Category Large Value
- Investment Style Mid Value
- Min. Initial Investment 3,000
- Status Open
- TTM Yield 1.43%
- Turnover 16%
USD | NAV as of Jul 18, 2026 | 1-Day Return as of Jul 18, 2026, 12:12 AM GMT+0
Morningstar’s Analysis SMVLX
Will SMVLX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 51.8
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Simon Property Group Inc | 6.53 | 260M | Real Estate |
Merck & Co Inc | 6.25 | 249M | Healthcare |
Cenovus Energy Inc | 6.04 | 240M | Energy |
Macerich Co | 6.03 | 240M | Real Estate |
APA Corp | 5.32 | 212M | Energy |
Amgen Inc | 4.97 | 198M | Healthcare |
D.R. Horton Inc | 4.80 | 191M | Consumer Cyclical |
Northern Institutional Treasury Premier | 4.59 | 183M | Cash and Equivalents |
NVR Inc | 4.01 | 160M | Consumer Cyclical |
American Express Co | 4.01 | 160M | Financial Services |
United States